Light Exposure on Pain in Hypermobile Ehlers-Danlos Syndrome
Investigation of Light Exposure on Pain Severity and Quality of Life in Individuals With Hypermobile Ehlers-Danlos Syndrome: A Pilot Study
New York Institute of Technology
30 participants
Nov 21, 2022
INTERVENTIONAL
Conditions
Summary
Chronic pain is a major complaint among many individuals living with hypermobile Ehlers Danlos Syndrome (hEDS) and may have a severe impact on quality of life and activities of daily living. Given the complexity of the disease's pathophysiology, effective treatments are limited. This investigation will examine the impacts of green light exposure on subject-reported pain severity and symptoms. Knowing whether this intervention can improve pain and quality of life in this population may offer valuable guidance to clinicians who treat hEDS patients and to hEDS patients themselves.
Eligibility
Inclusion Criteria3
- 18 years of age or older and able to speak, read, and understand English
- Diagnosed with hEDS
- Average numeric pain score of 5 out of 10 or greater over the 10 weeks prior to enrolling in the study and failure of medical therapy to control the pain
Exclusion Criteria4
- Initiation of any new analgesic therapy within 30 days of enrollment (note: chronic therapy with a stable regimen maintained for at least 30 days prior to enrollment is permitted)
- Serious mental illness, defined as distortions of perception, delusions, hallucinations, and unusual behaviors resulting in loss of contact with reality or Major Depression Disorder
- History of color blindness or uncorrected cataracts
- Receiving remuneration, or litigation pending, for their medical conditions
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Exposure to white LED light for 1-2 hours/day x 10 weeks
Exposure to green LED light for 1-2 hours/day x 10 weeks
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05561270